The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb

Multicenter observational prospective study of nivolumab (Nivo) as 2+ line treatment in advanced refractory NSCLC pts: Clinical and quality of life outcomes.
 
Rashida Orlova
No Relationships to Disclose
 
Konstantin Laktionov
Honoraria - AstraZeneca; BioCad; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; BioCad; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Pfizer; Roche
 
Larisa Bolotina
No Relationships to Disclose
 
Valeriy Vladimirovich Breder
Honoraria - Bayer; BioCad; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Roche; Takeda
Consulting or Advisory Role - Bayer; BioCad; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Roche
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche; Takeda
 
Anastasia Danilova
No Relationships to Disclose
 
Elena Filippova
No Relationships to Disclose
 
Anna Kornietskaya
No Relationships to Disclose
 
Mikhail Kramchaninov
No Relationships to Disclose
 
Eugenia Kushniruk
No Relationships to Disclose
 
Dilorom Latipova
No Relationships to Disclose
 
Evgeny Ledin
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst)
 
Anastasia Mochalova
No Relationships to Disclose
 
Fedor Vladimirovich Moiseenko
Honoraria - AstraZeneca; BioCad; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; MSD Oncology; Novartis; Pfizer/EMD Serono; Roche; Sanofi/Aventis; Takeda
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Roche; Takeda
Research Funding - BioCad (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Sanofi/Aventis
 
Tatiana Nikitina
No Relationships to Disclose
 
Sergey Orlov
No Relationships to Disclose
 
Svetlana Protsenko
Speakers' Bureau - AstraZeneca; BioCad; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; BioCad; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Ksenia Sarantseva
No Relationships to Disclose
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Anna Zinkovskaya
No Relationships to Disclose
 
Tatyana Ionova
Research Funding - Bristol-Myers Squibb (Inst); Takeda (Inst)